Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.330
+0.030 (2.31%)
At close: Oct 29, 2025, 4:00 PM EDT
1.400
+0.070 (5.26%)
After-hours: Oct 29, 2025, 7:42 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Immunotherapies and Vaccines
14.97M
Log In
Log In
Log In
Log In
Upgrade
Immunotherapies and Vaccines Growth
1766.46%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United Kingdom
14.97M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom and United States
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom and United States Growth
-
Log In
Log In
Log In
Log In
Upgrade